Sort
51,593 grants matching “hepatitis”
Hepatic TrkB-T1 signaling in NASH pathogenesis and resolution
$540,153Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2025 · DK
Impacts of universal access to HIV/AIDS care among HIV+ injection drug users
$540,096M-J Milloy · University Of British Columbia · U01 · FY2024 · DA
Structure and Immunogenicity of HIV-1 gp41 Membrane Proximal Region (MPR)
$540,091Richard Thomas Wyatt · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Phospholipid-Mediated Metabolic Control in the Pathogenesis of NAFLD
$540,091David E Cohen · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · DK
Quantitative Studies of Metabolic Organ Dynamics
$540,089Richard N. Bergman · University Of Southern California · R37 · FY2011 · DK
Insulin Resistance in Vascular Endothelial Cells and Foxo
$540,059Domenico Accili · Columbia University Health Sciences · P01 · FY2016 · HL
Insulin Resistance in Vascular Endothelial Cells and Foxo
$540,059Domenico Accili · Columbia University Health Sciences · P01 · FY2017 · HL
NASH-associated macrophages: regulation and role in disease pathogenesis
$540,053Jiandie D Lin · University Of Michigan At Ann Arbor · R01 · FY2023 · DK
Mechanisms of hepatic innate immune activation by HCV
$539,963Michael J Gale · University Of Washington · R01 · FY2019 · AI
Nuclear Envelope, Lipoprotein Metabolism, and Hepatic Steatosis
$539,893Howard J Worman · Columbia University Health Sciences · R01 · FY2019 · DK
Spinal cord injury causes liver pathology and metabolic dysfunction
$539,855Dana M McTigue · Ohio State University · R01 · FY2021 · DK
Alpha and Beta Cell Function in Normal and Diabetic Man
$539,828John E Gerich · University Of Rochester · R01 · FY2006 · DK
A neonatal mouse model to study retrovirus-specific humoral responses
$539,821Tatyana V. Golovkina · University Of Chicago · R01 · FY2020 · AI
Atherosclerosis And Peripheral Apoliprotein E Synthesis
$539,801Craig C Malbon · State University New York Stony Brook · R01 · FY2007 · HL
Contextual risk factors for hepatitis C among young persons who inject drugs
$539,772Basmattee Boodram · University Of Illinois At Chicago · R01 · FY2017 · DA
Regulation of Drug Metabolizing Enzyme Ontogeny
$539,737Ronald N Hines · Medical College Of Wisconsin · R01 · FY2009 · GM
Synthetic Cannabinoid Toxicity: Role of Biotransformation
$539,701Paul L Prather · Univ Of Arkansas For Med Scis · R01 · FY2017 · DA
A Randomized Trial of Vaccine Adherence in Young IDU
$539,686University Of California San Francisco · R01 · FY2004 · DA
Uganda Schistosomiasis Multidisciplinary Research Centre (U-SMRC)
$539,673Alison Elliott · Uganda Virus Research Institute · U01 · FY2022 · AI
Temporal control of differentiation and epigenetics of Exhausted CD8 T cells by Tox
$539,425E. John Wherry · University Of Pennsylvania · R01 · FY2020 · AI
HIV, HCV and Liver Disease Among Injection Drug Users in Chennai, India
$539,422Shruti H Mehta · Johns Hopkins University · R01 · FY2013 · DA
Genetic Approaches to Cholesterol Metabolism in Humans
$539,393Helen H. Hobbs · Ut Southwestern Medical Center · P01 · FY2007 · HL
Immunogenetic Mechanisms of Vaccine Response
$539,350Gregory A. Poland · Mayo Clinic Rochester · R01 · FY2008 · AI
Adapt Integrated Family CBT into HIV Prevention Intervention for Pregnant Women
$539,284William W Latimer · Johns Hopkins University · R01 · FY2008 · DA
Role of IgG Fc Glycan Composition in Vaccination
$539,278Jeffrey Victor Ravetch · Rockefeller University · U19 · FY2016 · AI